# Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

> **NCT02659475** · PHASE2 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 10 (actual)

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** PHEN/TPM ER (Qsymia®)

## Key facts

- **NCT ID:** NCT02659475
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02659475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02659475, "Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02659475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*